These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138 [TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Pickup J; Keen H Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953 [TBL] [Abstract][Full Text] [Related]
5. Fatalities Due to Failure of Continuous Subcutaneous Insulin Infusion Devices: A Report of Six Cases. Ziegler A; Williams T; Yarid N; Schultz DL; Bundock EA J Forensic Sci; 2019 Jan; 64(1):275-280. PubMed ID: 29940703 [TBL] [Abstract][Full Text] [Related]
6. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience. Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B; Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889 [TBL] [Abstract][Full Text] [Related]
7. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480 [TBL] [Abstract][Full Text] [Related]
9. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus]. Pfützner A; Berger S; Spinas G Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530 [TBL] [Abstract][Full Text] [Related]
10. Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type. Ross P; Gray AR; Milburn J; Kumarasamy IM; Wu F; Farrand S; Armishaw J; Wiltshire E; Rayns J; Tomlinson P; Wheeler BJ Acta Diabetol; 2016 Dec; 53(6):991-998. PubMed ID: 27585938 [TBL] [Abstract][Full Text] [Related]
11. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps. Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863 [TBL] [Abstract][Full Text] [Related]
12. Treatment of diabetes mellitus using an external insulin pump in clinical practice. Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117 [TBL] [Abstract][Full Text] [Related]
13. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps. Potti LG; Haines ST J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588 [TBL] [Abstract][Full Text] [Related]
14. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563 [TBL] [Abstract][Full Text] [Related]
15. [Continuous subcutaneous insulin infusion therapy. Prerequisites, indications and risks]. Sonnenberg GE; Spraul M; Chantelau EA; Berger M Dtsch Med Wochenschr; 1985 Nov; 110(48):1859-64. PubMed ID: 3933943 [No Abstract] [Full Text] [Related]
16. [Ketoacidosis in long-term therapy with insulin pumps. Incidence, causes, circumstances]. Walter H; Günther A; Timmler R; Mehnert H Med Klin (Munich); 1989 Dec; 84(12):565-8. PubMed ID: 2516236 [TBL] [Abstract][Full Text] [Related]
17. Acute complications associated with the use of insulin infusion pumps. Mecklenburg RS Diabetes Educ; 1989; 15(1):40-3. PubMed ID: 2491989 [TBL] [Abstract][Full Text] [Related]
19. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data. Kjærulff MLBG; Astrup BS J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551 [TBL] [Abstract][Full Text] [Related]
20. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion. Pańkowska E; Szypowska A; Lipka M; Skórka A Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]